Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Maintains Buy on BioNTech, Lowers Price Target to $283

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price target from $298 to $283.
byBenzinga Newsdesk
July 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price target from $298 to $283.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0